AdvaCare is a GMP manufacturer of Ceftazidime Powder for Injection.
Ceftazidime Powder for Injection is a cephalosporin antibiotic.
Ceftazidime is indicated for the treatment of respiratory tract infections, including lower respiratory tract infections in patients with cystic fibrosis; urinary tract infections; skin and soft tissue infections; biliary tract infections; intra-abdominal infections; and bone and joint infections.
Ceftazidime is also used to treat infections associated peritoneal dialysis and with continuous ambulatory peritoneal dialysis (CAPD) and meningitis due to aerobic gram-negative organisms.
As with all pharmaceuticals, some unwanted effects can occur from the use of Ceftazidime Powder. Always consult a doctor or health care professional for medical advice before use.
Common side effects include nausea, vomiting, diarrhea, stomach pain, headache, dizziness, numbness or tingly feeling, vaginal itching or discharge. Seek medical attention if any adverse effects occur.
For a comprehensive list of all possible effects, consult your doctor.
If any symptom persists or gets worse, or you notice any other symptom, then please call your doctor immediately.